DC Appeals Court to Review Marijuana’s Medical Benefits

It started with a coalition of disgruntled Americans, then a handful of governors took up the cause last year, and now — for the first time in nearly 20 years — a federal court will hear oral arguments in a lawsuit challenging the classification of cannabis as a dangerous drug without medical benefits.

In the case, Americans for Safe Access v. Drug Enforcement Administration, the court will be presented with scientific evidence regarding the medicinal effects of marijuana, and is expected to rule on whether or not the Drug Enforcement Administration acted appropriately in denying a petition to reclassify cannabis, filed by a collection of public interest organizations back in 2002.

“Medical marijuana patients are finally getting their day in court,” Joe Elford, chief counsel with ASA, said in a recent statement. “This is a rare opportunity for patients to confront politically motivated decision-making with scientific evidence of marijuana’s medical efficacy.”

Under federal law, a schedule I prohibited substance is defined as having “a high potential for abuse” and “no currently accepted medical use in treatment.” Heroine and LSD are classified alongside marijuana as schedule I, while cocaine, opium and methamphetamine are classified as schedule II, meaning they have “some accepted medical use.”

Other groups, including the American Medical Association, the American Nurses Association and the American Academy of Family Physicians, support medical access to the drug or its reclassification, while the California Medical Association has called for full legalization.

The current case will be heard by the U.S. Court of Appeals for the D.C. Circuit on October 16.

– Read the entire article at The Huffington Post.

Comments